Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 21, 2009Transplantation

Abrogation of Anti-HLA Antibodies via Proteasome Inhibition

View Full Paper
Ask AI
Bookmark
Share

Authors

HTHargovind L. TrivediPTPaul I. TerasakiAFA Feroz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Trivedi et al. (2009) studied this question.

synapsesocial.com/papers/6a9384e487a7e1ec251f4ea5https://doi.org/10.1097/tp.0b013e3181a4b91b
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma2004 · 743 citations
  2. 2A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma2003 · 2,653 citations
  3. 3Extensive Immunoglobulin Production Sensitizes Myeloma Cells for Proteasome Inhibition2007 · 403 citations